Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Group therapy for mental health in people with neurological disorders

Official title: Acceptance and Commitment Therapy- Based Group Therapy for Mental Health in Neurological Disorders

Run by Bielefeld University · NCT06897553 · Data updated 2026-11-12

This study is testing if group therapy using Acceptance and Commitment Therapy can help improve mental health for people with neurological disorders, including those recovering from COVID-19.

More Mental Health trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment44 (estimated)
SponsorBielefeld University
Academic / other
Locations1 site (Bielefeld)
StatusRecruiting
StartedDecember 1, 2024
Main results expectedAugust 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 27, 2025
Trial IDNCT06897553 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with neurological disorders who exhibit symptoms of depression, anxiety, or stress and have sufficient cognitive and language abilities.

Probably not a fit

Patients with severe mental disorders, such as dementia or psychosis, or those currently undergoing other forms of psychotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of Acceptance and Commitment Therapy (ACT) in improving mental health outcomes for individuals with various neurological disorders, including those recovering from COVID-19. Participants will engage in eight weekly group therapy sessions, each lasting 100 minutes, focusing on enhancing psychological flexibility and addressing issues such as depression, anxiety, and stress. The study will also explore the relationship between executive functions and the success of therapy, particularly how cognitive abilities may influence social participation and mental health improvements. The research builds on previous findings that indicated the feasibility and potential benefits of ACT for stroke survivors.

Why it matters

Potential benefit: If successful, this therapy could significantly improve mental health and quality of life for patients with neurological disorders.

How similar studies have gone: Previous studies have shown promising results for ACT in similar populations, indicating potential efficacy for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Value above a cut-off of the DASS-21 subscales (depression \> 10, anxiety \> 6, and stress \> 10)
* Sufficient cognition and language ability (clinical rating)
* Sufficient therapy motivation (clinical rating)

Exclusion Criteria:

* Behavioral disorders (e.g., high irritability or apathy in clinical rating)
* Other severe mental disorder (dementia, psychosis, personality disorders, intellectual disability)
* Simultaneous psychotherapy or neuropsychological therapy

Where it's running

  • Neuropsychologische Hochschulambulanz Bielefeld
    Bielefeld, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.